Cargando…

P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA

Detalles Bibliográficos
Autores principales: Wang, L., Xu, H., Liang, J., Li, Y., Shi, L., Xiao, B., Huang, J., Xu, X., Zhang, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429684/
http://dx.doi.org/10.1097/01.HS9.0000848716.65161.13
_version_ 1784779535204483072
author Wang, L.
Xu, H.
Liang, J.
Li, Y.
Shi, L.
Xiao, B.
Huang, J.
Xu, X.
Zhang, X.
author_facet Wang, L.
Xu, H.
Liang, J.
Li, Y.
Shi, L.
Xiao, B.
Huang, J.
Xu, X.
Zhang, X.
author_sort Wang, L.
collection PubMed
description
format Online
Article
Text
id pubmed-9429684
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94296842022-08-31 P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA Wang, L. Xu, H. Liang, J. Li, Y. Shi, L. Xiao, B. Huang, J. Xu, X. Zhang, X. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429684/ http://dx.doi.org/10.1097/01.HS9.0000848716.65161.13 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Wang, L.
Xu, H.
Liang, J.
Li, Y.
Shi, L.
Xiao, B.
Huang, J.
Xu, X.
Zhang, X.
P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
title P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
title_full P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
title_fullStr P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
title_full_unstemmed P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
title_short P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
title_sort p1465: initial safety and efficacy study of rm-001, autologous hbg1/2 promoter-modified cd34+ hematopoietic stem and progenitor cells, in transfusion-dependent βeta-thalassemia
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429684/
http://dx.doi.org/10.1097/01.HS9.0000848716.65161.13
work_keys_str_mv AT wangl p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia
AT xuh p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia
AT liangj p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia
AT liy p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia
AT shil p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia
AT xiaob p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia
AT huangj p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia
AT xux p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia
AT zhangx p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia